Therapeutic efficacy of concurrently delivering a Dox and a Pgp inhibitor from an ISFI was evaluated over 20 days Tumor growth studies (Fig. 8) showed a significant inhibition of tumor growth when co-delivering Dox with Val compared to all other groups. This evidence concerns the gene PGP and neoplasm.